Literature DB >> 29433946

Definition and diagnosis of asthma-COPD overlap (ACO).

Satoru Yanagisawa1, Masakazu Ichinose2.   

Abstract

It is now widely recognized that asthma and COPD can coexist as asthma-COPD overlap (ACO), but the preliminary attempts at providing universal guidelines for the diagnosis of ACO still need to be improved. We believe that a case can be made for devising guidelines for the diagnosis of this increasingly common disease that are specific to Japan. In this paper, we present our consensus-based description of ACO which we believe is realistic for use in our country. In addition, we cite the scientific evidence for our own "objective" features used to develop the criteria for COPD and asthma diagnosis. We acknowledge that they will need to be validated and updated over time, but hope the results will encourage further research on the characteristics and treatment of this commonly encountered clinical problem.
Copyright © 2018 Japanese Society of Allergology. Production and hosting by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Airway responsiveness; Allergic rhinitis; CT; Eosinophil; Exhaled NO

Mesh:

Year:  2018        PMID: 29433946     DOI: 10.1016/j.alit.2018.01.002

Source DB:  PubMed          Journal:  Allergol Int        ISSN: 1323-8930            Impact factor:   5.836


  19 in total

1.  Is Asthma and COPD Overlap Syndrome Weather and Environment Sensitive?

Authors:  Serdar Kalemci; Aydın Sarıhan; Arife Zeybek
Journal:  Lung       Date:  2019-12-04       Impact factor: 2.584

2.  Ulinastatin protects the lungs of COPD rats through the HMGB1/TLR4 signaling pathway.

Authors:  Wei Liu; Zhiguang Liu; Weidong Zhang; Shaoxi Cai
Journal:  Oncol Lett       Date:  2018-07-11       Impact factor: 2.967

3.  Clinical Indicators for Asthma-COPD Overlap: A Systematic Review and Meta-Analysis.

Authors:  Junjie Peng; Min Wang; Yanqiu Wu; Yongchun Shen; Lei Chen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-10-12

4.  Time To Revise COPD Treatment Algorithm.

Authors:  Kazuto Matsunaga; Keiji Oishi; Marc Miravitlles; Antonio Anzueto
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-09-27

5.  Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD: A Subgroup Analysis of the KRONOS Study.

Authors:  Masakazu Ichinose; Yasushi Fukushima; Yoshikazu Inoue; Osamu Hataji; Gary T Ferguson; Klaus F Rabe; Nobuya Hayashi; Hiroshi Okada; Mami Takikawa; Eric Bourne; Shaila Ballal; Kiernan DeAngelis; Magnus Aurivillius; Paul Dorinsky; Colin Reisner
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-12-23

Review 6.  ACO (Asthma-COPD Overlap) Is Independent from COPD, a Case in Favor: A Systematic Review.

Authors:  Naoya Fujino; Hisatoshi Sugiura
Journal:  Diagnostics (Basel)       Date:  2021-05-11

7.  Enhanced risk of traumatic brain injury in patients with chronic obstructive pulmonary disease.

Authors:  Tang-Hsiu Huang; Chiung-Zuei Chen; Hung-I Kuo; Hong-Ping Er; Sheng-Hsiang Lin
Journal:  J Investig Med       Date:  2019-12-31       Impact factor: 2.895

8.  Eicosanoids metabolized through LOX distinguish asthma-COPD overlap from COPD by metabolomics study.

Authors:  Chuanxu Cai; Xiqing Bian; Mingshan Xue; Xiaoqing Liu; Haisheng Hu; Jingxian Wang; Song Guo Zheng; Baoqing Sun; Jian-Lin Wu
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-08-06

9.  Associations among chronic obstructive pulmonary disease with asthma, pneumonia, and corticosteroid use in the general population.

Authors:  Jun-Jun Yeh; Cheng-Li Lin; Chia-Hung Kao
Journal:  PLoS One       Date:  2020-02-24       Impact factor: 3.240

Review 10.  Innate Lymphoid Cells in the Airways: Their Functions and Regulators.

Authors:  Keisuke Orimo; Hirohisa Saito; Kenji Matsumoto; Hideaki Morita
Journal:  Allergy Asthma Immunol Res       Date:  2020-05       Impact factor: 5.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.